IL-1 signal affects both protection and pathogenesis of virus-induced chronic CNS demyelinating disease

Journal of Neuroinflammation

Volumn 9, Issue , 2012, Pages

  Kim, Byung S ^a   Jin, Young Hee ^a   Meng, Liping ^a   Hou, Wanqiu ^a,c   Kang, Hyun S ^a   Park, Hey S ^a   Koh, Chang Sung ^b  

^a NORTHWESTERN UNIVERSITY   (United States)

^b SHINSHU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

CNS; Demyelination; IL 1; IL 1R; IL 1R KO mice; T cell responses; Th17; TMEV

Indexed keywords

INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; PROGRAMMED DEATH 1 LIGAND 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELLULAR IMMUNITY; CELLULAR IMMUNODEFICIENCY; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RESPONSE; DEMYELINATING DISEASE; DISEASE EXACERBATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; GENE; HISTOPATHOLOGY; HOST RESISTANCE; IL1ALPHA GENE; IL1BETA GENE; INFECTION PREVENTION; INFECTION RESISTANCE; INFECTION SENSITIVITY; LYMPHOCYTIC INFILTRATION; MOUSE; MURINE ENCEPHALOMYELITIS VIRUS; NONHUMAN; PERSISTENT VIRUS INFECTION; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION; TH17 CELL; VIRUS ENCEPHALITIS; VIRUS PATHOGENESIS;

EID: 84866168469     PISSN: None     EISSN: 17422094     Source Type: Journal    
DOI: 10.1186/1742-2094-9-217     Document Type: Article

References (48)

1. Dinarello CA. Immunological and inflammatory functions of the interleukin-1 family. Annu Rev Immunol 2009, 27:519-550. 10.1146/annurev.immunol.021908.132612, 19302047.
2. Szretter KJ, Gangappa S, Lu X, Smith C, Shieh WJ, Zaki SR, Sambhara S, Tumpey TM, Katz JM. Role of host cytokine responses in the pathogenesis of avian H5N1 influenza viruses in mice. J Virol 2007, 81:2736-2744. 10.1128/JVI.02336-06, 1866007, 17182684.
3. Casanova JL, Abel L, Quintana-Murci L. Human TLRs and IL-1Rs in host defense: natural insights from evolutionary, epidemiological, and clinical genetics. Annu Rev Immunol 2011, 29:447-491. 10.1146/annurev-immunol-030409-101335, 21219179.
4. Dinarello CA. Interleukin-1 in the pathogenesis and treatment of inflammatory diseases. Blood 2011, 117:3720-3732. 10.1182/blood-2010-07-273417, 3083294, 21304099.
5. Sims JE, Smith DE. The IL-1 family: regulators of immunity. Nat Rev Immunol 2010, 10:89-102.
6. Schroder K, Tschopp J. The inflammasomes. Cell 2010, 140:821-832. 10.1016/j.cell.2010.01.040, 20303873.
7. Netea MG, Simon A, van de Veerdonk F, Kullberg BJ, Van der Meer JW, Joosten LA. IL-1beta processing in host defense: beyond the inflammasomes. PLoS Pathog 2010, 6:e1000661. 10.1371/journal.ppat.1000661, 2829053, 20195505.
8. Kanneganti TD. Central roles of NLRs and inflammasomes in viral infection. Nat Rev Immunol 2010, 10:688-698. 10.1038/nri2851, 20847744.
9. Pevear DC, Calenoff M, Rozhon E, Lipton HL. Analysis of the complete nucleotide sequence of the picornavirus Theiler's murine encephalomyelitis virus indicates that it is closely related to cardioviruses. J Virol 1987, 61:1507-1516. 254129, 3033278.
10. Lipton HL, Dal-Canto MC. Chronic neurologic disease in Theiler's virus infection of SJL/J mice. J Neurol Sci 1976, 30:201-207. 10.1016/0022-510X(76)90267-7, 978224.
11. Dal Canto MC, Lipton HL. Multiple sclerosis. Animal model:Theiler's virus infection in mice. Am J Path 1977, 88:497-500. 2032181, 195474.
12. Dal Canto MC, Kim BS, Miller SD, Melvold RW. Theiler's murine encephalomyelitis virus (TMEV)-induced demyelination: a model for human multiple clerosis. Methods 1996, 10:453-461. 10.1006/meth.1996.0123, 8954856.
13. Palma JP, Kim BS. The scope and activation mechanisms of chemokine gene expression in primary astrocytes following infection with Theiler's virus. J Neuroimmunol 2004, 149:121-129. 10.1016/j.jneuroim.2003.12.025, 15020072.
14. So EY, Kang MH, Kim BS. Induction of chemokine and cytokine genes in astrocytes following infection with Theiler's murine encephalomyelitis virus is mediated by the Toll-like receptor 3. Glia 2006, 53:858-867. 10.1002/glia.20346, 16586493.
15. So EY, Kim BS. Theiler's virus infection induces TLR3-dependent upregulation of TLR2 critical for proinflammatory cytokine production. Glia 2009, 57:1216-1226. 10.1002/glia.20843, 2706926, 19191335.
16. Kato H, Takeuchi O, Sato S, Yoneyama M, Yamamoto M, Matsui K, Uematsu S, Jung A, Kawai T, Ishii KJ, Yamaguchi O, Otsu K, Tsujimura T, Koh CS, Reis-e-Sousa C, Matsuura Y, Fujita T, Akira S. Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses. Nature 2006, 441:101-105. 10.1038/nature04734, 16625202.
17. Hou W, Kang HS, Kim BS. Th17 cells enhance viral persistence and inhibit T cell cytotoxicity in a model of chronic virus infection. J Exp Med 2009, 206:313-328. 10.1084/jem.20082030, 2646583, 19204109.
18. Pullen LC, Park SH, Miller SD, Dal-Canto MC, Kim BS. Treatment with bacterial LPS renders genetically resistant C57BL/6 mice susceptible to Theiler's virus-induced demyelinating disease. J Immunol 1995, 155:4497-4503.
19. Sutton C, Brereton C, Keogh B, Mills KH, Lavelle EC. A crucial role for interleukin (IL)-1 in the induction of IL-17-producing T cells that mediate autoimmune encephalomyelitis. J Exp Med 2006, 203:1685-1691. 10.1084/jem.20060285, 2118338, 16818675.
20. Kang BS, Lyman MA, Kim BS. The majority of infiltrating CD8+ T cells in the central nervous system of susceptible SJL/J mice infected with Theiler's virus are virus specific and fully functional. J Virol 2002, 76:6577-6585. 10.1128/JVI.76.13.6577-6585.2002, 136254, 12050370.
21. Lyman MA, Myoung J, Mohindru M, Kim BS. Quantitative, not qualitative, differences in CD8(+) T cell responses to Theiler's murine encephalomyelitis virus between resistant C57BL/6 and susceptible SJL/J mice. Eur J Immunol 2004, 34:2730-2739. 10.1002/eji.200324811, 15368289.
22. Fuller AC, Kang B, Kang HK, Yahikozowa H, Dal-Canto MC, Kim BS. Gender Bias in Theiler's Virus-Induced Demyelinating Disease Correlates with the Level of Antiviral Immune Responses. J Immunol 2005, 175:3955-3963.
23. Mohindru M, Kang B, Kim BS. Initial capsid-specific CD4(+) T cell responses protect against Theiler's murine encephalomyelitisvirus-induced demyelinating disease. Eur J Immunol 2006, 36:2106-2115. 10.1002/eji.200535785, 16761311.
24. Menu P, Vince JE. The NLRP3 inflammasome in health and disease: the good, the bad and the ugly. Clin Exp Immunol 2011, 166:1-15. 10.1111/j.1365-2249.2011.04440.x, 21762124.
25. Myoung J, Bahk YY, Kang HS, Dal-Canto MC, Kim BS. Anticapsid immunity level, not viral persistence level, correlates with the progression of Theiler's virus-induced demyelinating disease in viral P1-transgenic mice. J Virol 2008, 82:5606-5617. 10.1128/JVI.02442-07, 2395227, 18353953.
26. Acosta-Rodriguez EV, Napolitani G, Lanzavecchia A, Sallusto F. Interleukins 1beta and 6 but not transforming growth factor-beta are essential for the differentiation of interleukin 17-producing human T helper cells. Nat Immunol 2007, 8:942-949.
27. Rao DA, Eid RE, Qin L, Yi T, Kirkiles-Smith NC, Tellides G, Pober JS. Interleukin (IL)-1 promotes allogeneic T cell intimal infiltration and IL-17 production in a model of human artery rejection. J Exp Med 2008, 205:3145-3158. 10.1084/jem.20081661, 2605225, 19075290.
28. Keir ME, Butte MJ, Freeman GJ, Sharpe AH. PD-1 and its ligands in tolerance and immunity. Annu Rev Immunol 2008, 26:677-704. 10.1146/annurev.immunol.26.021607.090331, 18173375.
29. Anderson AC, Anderson DE, Bregoli L, Hastings WD, Kassam N, Lei C, Chandwaskar R, Karman J, Su EW, Hirashima M, Bruce JN, Kane LP, Kuchroo VK, Hafler DA. Promotion of tissue inflammation by the immune receptor Tim-3 expressed on innate immune cells. Science 2007, 318:1141-1143. 10.1126/science.1148536, 18006747.
30. Kim BS, Palma JP, Inoue A, Koh CS. Pathogenic immunity in Theiler's virus-induced demyelinating disease: a viral model for multiple sclerosis. Arch Immunol Ther Exp 2000, 48:373-379.
31. Kim BS, Lyman MA, Kang BS, Kang HK, Lee HG, Mohindru M, Palma JP. Pathogenesis of virus-induced immune-mediated demyelination. Immunol Res 2001, 24:121-130. 10.1385/IR:24:2:121, 11594451.
32. Yauch RL, Palma JP, Yahikozawa H, Koh CS, Kim BS. Role of individual T-cell epitopes of Theiler's virus in the pathogenesis of demyelination correlates with the ability to induce a Th1 response. J Virol 1998, 72:6169-6174. 110426, 9621084.
33. Jin YH, Kang B, Kim BS. Theiler's virus infection induces a predominant pathogenic CD4+ T cell response to RNA polymerase in susceptible SJL/J mice. J Virol 2009, 83:10981-10992. 10.1128/JVI.01398-09, 2772789, 19706717.
34. Lledo A, Borrell J, Guaza C. Dexamethasone regulation of interleukin-1-receptors in the hippocampus of Theiler's virus-infected mice: effects on virus-mediated demyelination. Eur J Pharmacol 1999, 372:75-83. 10.1016/S0014-2999(99)00187-9, 10374717.
35. Mannie MD, Dinarello CA, Paterson PY. Interleukin 1 and myelin basic protein synergistically augment adoptive transfer activity of lymphocytes mediating experimental autoimmune encephalomyelitis in Lewis rats. J Immunol 1987, 138:4229-4235.
36. Jacobs CA, Baker PE, Roux ER, Picha KS, Toivola B, Waugh S, Kennedy MK. Experimental autoimmune encephalomyelitis is exacerbated by IL-1 alpha and suppressed by soluble IL-1 receptor. J Immunol 1991, 146:2983-2989.
37. Li Q, Powell N, Zhang H, Belevych N, Ching S, Chen Q, Sheridan J, Whitacre C, Quan N. Endothelial IL-1R1 is a critical mediator of EAE pathogenesis. Brain Behav Immun 2011, 25:160-167. 10.1016/j.bbi.2010.09.009, 2991628, 20854891.
38. Pott Godoy MC, Tarelli R, Ferrari CC, Sarchi MI, Pitossi FJ. Central and systemic IL-1 exacerbates neurodegeneration and motor symptoms in a model of Parkinson's disease. Brain 2008, 131:1880-1894. 10.1093/brain/awn101, 2442423, 18504291.
39. Shaw MH, Kamada N, Kim YG, Nunez G. Microbiota-induced IL-1beta, but not IL-6, is critical for the development of steady-state TH17 cells in the intestine. J Exp Med 2012, 209:251-258. 10.1084/jem.20111703, 3280878, 22291094.
40. Brinster C, Shevach EM. Costimulatory effects of IL-1 on the expansion/differentiation of CD4 + CD25 + Foxp3+ and CD4 + CD25 + Foxp3- T cells. J Leukoc Biol 2008, 84:480-487. 10.1189/jlb.0208085, 2493074, 18477692.
41. Richards MH, Getts MT, Podojil JR, Jin YH, Kim BS, Miller SD. Virus expanded regulatory T cells control disease severity in the Theiler's virus mouse model of MS. J Autoimmun 2011, 36:142-154. 10.1016/j.jaut.2010.12.005, 3046315, 21273044.
42. Giulian D, Lachman LB. Interleukin-1 stimulation of astroglial proliferation after brain injury. Science 1985, 228:497-499. 10.1126/science.3872478, 3872478.
43. Jin YH, Mohindru M, Kang MH, Fuller AC, Kang B, Gallo D, Kim BS. Differential virus replication, cytokine production, and antigen-presenting function by microglia from susceptible and resistant mice infected with Theiler's virus. J Virol 2007, 81:11690-11702. 10.1128/JVI.01034-07, 2168808, 17715222.
44. Prow NA, Irani DN. The inflammatory cytokine, interleukin-1 beta, mediates loss of astroglial glutamate transport and drives excitotoxic motor neuron injury in the spinal cord during acute viral encephalomyelitis. J Neurochem 2008, 105:1276-1286. 10.1111/j.1471-4159.2008.05230.x, 2579753, 18194440.
45. Rubio N. Demonstration of the presence of an interleukin-1 receptor on the surface of murine astrocytes and its regulation by cytokines and Theiler's virus. Immunology 1994, 82:178-183. 1414823, 7927486.
46. Miller LS, O'Connell RM, Gutierrez MA, Pietras EM, Shahangian A, Gross CE, Thirumala A, Cheung AL, Cheng G, Modlin RL. MyD88 mediates neutrophil recruitment initiated by IL-1R but not TLR2 activation in immunity against Staphylococcus aureus. Immunity 2006, 24:79-91. 10.1016/j.immuni.2005.11.011, 16413925.
47. Nambu A, Nakae S, Iwakura Y. IL-1beta, but not IL-1alpha, is required for antigen-specific T cell activation and the induction of local inflammation in the delayed-type hypersensitivity responses. Int Immunol 2006, 18:701-712.
48. Ben-Sasson SZ, Hu-Li J, Quiel J, Cauchetaux S, Ratner M, Shapira I, Dinarello CA, Paul WE. IL-1 acts directly on CD4 T cells to enhance their antigen-driven expansion and differentiation. Proc Natl Acad Sci USA 2009, 106:7119-7124. 10.1073/pnas.0902745106, 2678417, 19359475.